Patient Intelligence: Designing Clinical Trials in the COVID-19 Era

In the age of COVID-19, patients can’t wait for new vaccines and therapies to come to the market. That is why even in these challenging times, Covance has been focused more than ever on understanding the patient perspective on clinical trial participation. As social distancing has become the new normal, …

covid-19 covance labcorp diagnostics drug development

Covance and LabCorp Deliver Unmatched COVID-19 Diagnostic and Therapeutic Applications

We’re in this together: How Covance and LabCorp are delivering unmatched acceleration of COVID-19 diagnostic and therapeutic applications Accelerating much needed COVID-19 testing, vaccines and treatment options across the world can’t be done alone. We’re in this together and ready to apply our unique combination of solutions that blend Covance …

Speeding Hand Disinfectant Products into the EU Market in Response to the Demand Driven by Covid-19

An unprecedented challenge The coronavirus (Covid-19) pandemic has increased the demand for hand disinfectants, driven by recommendations from bodies such as the WHO. Hand washing is a vital measure for reducing the risk of contracting the virus. The WHO specifically recommends that all individuals “Regularly and thoroughly clean your hands …

Navigating COVID-19: The Importance of a Nimble Reimbursement Call Center Operation

The impact of COVID-19 on reimbursement call center operations has the potential to be significant. However, a proactive crisis management plan and a dispersed, redundant operating model can go a long way towards safeguarding your patient support programs. As governments and citizens address challenges posed by this global pandemic, many …